Physician profile
Rodolfo Quintero
NPI 1053416958
$2,549.85
in general payments reported to CMS, 2019-2025
8 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $1,437 · 2022: $134 · 2023: $192 · 2024: $392 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,707.57 | 2019-2025 | Menopur |
| Emd Serono, INC. | $485.72 | 2019-2024 | |
| Mindray Ds USA, INC. | $195.93 | 2023-2024 | A7 Anesthesia System |
| Coopersurgical, INC. | $72.09 | 2024 | Stripper, Origio Sequential Fert |
| Merck Sharp & Dohme LLC | $28.30 | 2019 | |
| Organon LLC | $25.33 | 2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Therapeuticsmd, INC. | $18.25 | 2019 | |
| Hologic Sales and Service, LLC | $16.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Quintero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.